Seres Therapeutics, Inc. (MCRB)
$2.68-1.11%Close
SELLCRISIS · day 23
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $26M
- Beta
- 0.21
- P/E (TTM)
- -1.20
- Short % float
- 4.28%
- Days to cover
- 5.2
- SI change
- +4.3%
- 1W
- -5.96%
- 1M
- -46.51%
- vs SPY 1W
- -6.39%
- vs SPY 1M
- -48.57%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on MCRB?
- LOPJLB’s latest quantitative signal on Seres Therapeutics, Inc. (MCRB) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is MCRB in?
- Seres Therapeutics, Inc. (MCRB) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Seres Therapeutics, Inc. (MCRB) do?
- Seres Therapeutics, Inc. is a pioneering microbiome therapeutics firm dedicated to engineering bacterial consortia that modulate host cells and tissues to combat various diseases. Their flagship therapeutic, SER-109, an oral microbiome treatment, has successfully concluded Phase III clinical trials for the management of Clostridioides difficile infection (CDI). The company's pipeline further en…